Clinical Trials Directory

Trials / Unknown

UnknownNCT00428506

Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction

Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction in Cirrhotic Patients With Ascites

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
University of Turin, Italy · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the infusion of albumin 4 gr per liter of ascites removed is as effective as the infusion of albumin 8 gr per liter of ascites removed in the prevention of post-paracentesis circulatory dysfunction

Detailed description

Large-volume paracentesis associated with plasma volume expansion is the first-line treatment of tense ascites in cirrhotic patients. When paracentesis is performed without volume expansion, an high proportion of patients develop a complication named post-paracentesis circulatory dysfunction, which is characterized by a marked activation of the renin-angiotensin-aldosterone system. PPCD has been associated with renal impairment, rapid recurrence of ascites and shorter survival. Infusion of albumin is very effective in the prevention of PPCD, but has sever inherent drawbacks: the theoretical possibility of transmission of infectious diseases and the high costs. Other synthetic plasma volume expanders have been proposed in the last decades, but they are less effective than albumin when large (\> 5 L) volume paracentesis are performed. Albumin is conventionally given in a dosage of 8 gr per liter of ascites removed; however no information has yet been reported on the use of lower dosages of albumin in this context. This would be interesting, because of the obvious advantages in terms of costs reduction. The aim of the present study is to compare the efficacy of the infusion of albumin 4 gr vs 8 gr per liter of ascites removed in the prevention of PPCD.

Conditions

Interventions

TypeNameDescription
DRUGalbumin 4 gr/L ascites removedalbumin 4 gr/L ascites removed
DRUGalbumin 8 gr/L ascites removedalbumin 8 gr/L ascites removed

Timeline

Start date
2007-02-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2007-01-30
Last updated
2008-04-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00428506. Inclusion in this directory is not an endorsement.